ExodusPoint Capital Management’s Health Catalyst HCAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-97,117	Closed	-$440K	–	1665
2025 Q1	$440K	Buy	97,117 +82,003	+543%	+$434K	﹤0.01%	1139
2024 Q4	$107K	Buy	+15,114	New	+$120K	﹤0.01%	1402
2024 Q3	–	Sell	-21,806	Closed	-$139K	–	1797
2024 Q2	$139K	Sell	21,806 -45,328	-68%	-$291K	﹤0.01%	1414
2024 Q1	$506K	Buy	67,134 +9,644	+17%	+$88K	﹤0.01%	1136
2023 Q4	$532K	Sell	57,490 -10,707	-16%	-$87.5K	﹤0.01%	1016
2023 Q3	$690K	Buy	68,197 +2,670	+4%	+$31.9K	0.01%	1116
2023 Q2	$819K	Sell	65,527 -148,176	-69%	-$1.76M	0.01%	1178
2023 Q1	$2.49M	Buy	213,703 +61,124	+40%	+$779K	0.02%	794
2022 Q4	$1.62M	Buy	152,579 +11,588	+8%	+$112K	0.02%	739
2022 Q3	$1.37M	Buy	140,991 +111,741	+382%	+$1.48M	0.02%	967
2022 Q2	$424K	Sell	29,250 -38,674	-57%	-$659K	0.01%	1419
2022 Q1	$1.77M	Buy	67,924 +49,305	+265%	+$1.4M	0.02%	842
2021 Q4	$738K	Buy	18,619 +6,016	+48%	+$274K	0.01%	1227
2021 Q3	$630K	Buy	+12,603	New	+$687K	0.01%	1262
2020 Q3	–	Sell	-9,195	Closed	-$268K	–	1939
2020 Q2	$268K	Buy	9,195 +1,177	+15%	+$32.5K	0.01%	1371
2020 Q1	$210K	Buy	+8,018	New	+$245K	0.01%	770